<?xml version="1.0"?>
<?xml-stylesheet type='text/xsl' href='../../ld1.xsl'?>
<LOBBYINGDISCLOSURE1>
   <imported>N</imported>
   <pages>2</pages>
   <regType>2</regType>
   <organizationName>POLICY DIRECTIONS INC.</organizationName>
   <prefix></prefix>
   <firstName></firstName>
   <lastName></lastName>
   <address1>818 CONNECTICUT AVENUE, NW, #950</address1>
   <address2></address2>
   <city>WASHINGTON, DC</city>
   <state>DC</state>
   <zip>20006</zip>
   <zipext></zipext>
   <country>USA</country>
   <principal_city></principal_city>
   <principal_state></principal_state>
   <principal_zip></principal_zip>
   <principal_zipext></principal_zipext>
   <principal_country></principal_country>
   <registrantGeneralDescription>Government Relations</registrantGeneralDescription>
   <selfSelect>N</selfSelect>
   <clientName>Nutrition &amp; Medical Foods Coalition (Ad Hoc Coalition)</clientName>
   <clientAddress>818 Connecticut Avenue, NW, #950</clientAddress>
   <clientCity>Washington</clientCity>
   <clientState>DC</clientState>
   <clientZip>20006</clientZip>
   <clientZipExt></clientZipExt>
   <clientCountry>USA</clientCountry>
   <prinClientCity></prinClientCity>
   <prinClientState></prinClientState>
   <prinClientZip></prinClientZip>
   <prinClientZipExt></prinClientZipExt>
   <prinClientCountry></prinClientCountry>
   <clientGeneralDescription>Producers of Medical Foods</clientGeneralDescription>
   <senateID>31747</senateID>
   <houseID>321120099</houseID>
   <lobbyists>
      <lobbyist>
         <lobbyistFirstName>STEVE </lobbyistFirstName>
         <lobbyistLastName>KOPPERUD</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition></coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>JILL HOMER</lobbyistFirstName>
         <lobbyistLastName>STEWART</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Rep. Peter Visclosky - Legislative Director</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>"</lobbyistFirstName>
         <lobbyistLastName>"</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Rep. Robert Weygand, Staff Assistant</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>"</lobbyistFirstName>
         <lobbyistLastName>"</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Sen. Dianne Feinstein, Staff Assistant</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
      <lobbyist>
         <lobbyistFirstName>"</lobbyistFirstName>
         <lobbyistLastName>"</lobbyistLastName>
         <lobbyistSuffix></lobbyistSuffix>
         <coveredPosition>Rep. Gary Condit, Intern</coveredPosition>
         <lobbyistNew>Y</lobbyistNew>
      </lobbyist>
   </lobbyists>
   <alis>
      <ali_Code>FOO</ali_Code>
      <ali_Code>MMM</ali_Code>
      <ali_Code>HCR</ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
      <ali_Code></ali_Code>
   </alis>
   <specific_issues>Medicare Part D reimbursement.
FDA regulation of medical foods.</specific_issues>
   <affiliatedUrl></affiliatedUrl>
   <affiliatedOrgs>
      <affiliatedOrg>
         <affiliatedOrgName>Primus Pharmaceuticals, Inc.</affiliatedOrgName>
         <affiliatedOrgAddress>7373 N. Scottsdale Road, Suite B-200</affiliatedOrgAddress>
         <affiliatedOrgCity>Scottsdale</affiliatedOrgCity>
         <affiliatedOrgState>AZ</affiliatedOrgState>
         <affiliatedOrgZip>85253</affiliatedOrgZip>
         <affiliatedOrgCountry>USA</affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName>Prismic Pharmaceuticals, Inc.</affiliatedOrgName>
         <affiliatedOrgAddress>8283 N. Hayden Road, Suite 100</affiliatedOrgAddress>
         <affiliatedOrgCity>Scottsdale</affiliatedOrgCity>
         <affiliatedOrgState>AZ</affiliatedOrgState>
         <affiliatedOrgZip>85258</affiliatedOrgZip>
         <affiliatedOrgCountry>USA</affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
      <affiliatedOrg>
         <affiliatedOrgName>Targeted Medical Pharma, Inc.</affiliatedOrgName>
         <affiliatedOrgAddress>2980 Beverly Glen Circle, Suite 301</affiliatedOrgAddress>
         <affiliatedOrgCity>Los Angeles</affiliatedOrgCity>
         <affiliatedOrgState>CA</affiliatedOrgState>
         <affiliatedOrgZip>90077</affiliatedOrgZip>
         <affiliatedOrgCountry>USA</affiliatedOrgCountry>
         <affiliatedPrinOrgCity></affiliatedPrinOrgCity>
         <affiliatedPrinOrgState></affiliatedPrinOrgState>
         <affiliatedPrinOrgCountry></affiliatedPrinOrgCountry>
      </affiliatedOrg>
   </affiliatedOrgs>
   <foreignEntities>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
      <foreignEntity>
         <name></name>
         <address></address>
         <city></city>
         <state></state>
         <country></country>
         <prinCity></prinCity>
         <prinState></prinState>
         <prinCountry></prinCountry>
         <contribution></contribution>
         <ownership_Percentage></ownership_Percentage>
      </foreignEntity>
   </foreignEntities>
   <reportYear>2014</reportYear>
   <reportType>RR</reportType>
   <effectiveDate>02/26/2014</effectiveDate>
   <printedName>STEVE KOPPERUD, EXECUTIVE VICE PRESIDENT</printedName>
   <signedDate>02/26/2014</signedDate>
</LOBBYINGDISCLOSURE1>